Sabra Health Care REIT, Inc. SBRA
20.44 USD +0.18 (+0.89%)
Regular-session close
20.44 0.00 0.00%
After hours · Nov 13, 5:23 PM ET
20.22 Day range 20.48
17.67 52-week range 22.39
- YTD
- +7.92%
- 1 year
- +9.42%
- Market cap
- 5.35B
- Revenue (ttm)
- 924.30M
- Profit margin
- 7.74%
- EPS (ttm)
- 0.27
- Shares out
- 261.96M
- P/E ratio
- 75.70
- Forward P/E
- 28.19
- Dividend
- 1.20 (5.83%)
- Ex-dividend date
- Nov 13, 2026
- YTD return
- +7.92%
- 1-year return
- +9.42%
- Volume
- 2.33M
- Avg volume
- 2.44M
- Open
- 20.31
- Previous close
- 20.26
- Day's range
- 20.22 – 20.48
- 52-week range
- 17.67 – 22.39
- Beta
- 0.64
- Analysts
- Buy
- Price target
- 22.64 (+10.8%)
- Earnings date
- Feb 11, 2027
5D -0.71 (-3.36%)
Key statistics
- Enterprise value
- 7.76B
- PEG ratio
- 5.28
- Price / sales
- 5.79
- Price / book
- 1.89
- Dividend yield
- 5.83%
- Payout ratio
- 444.44%
- Revenue growth
- 31.60%
- Free cash flow
- 299.66M
- Total cash
- 67.65M
- Total debt
- 2.44B
- Return on equity
- 2.52%
- Short % of float
- 9.27%
- 50-day average
- 19.89
- 200-day average
- 20.05
Fundamental scorecard
8 of 25 checks passed on SBRA’s reported financials
8of 25 checks passed
- Value 0 of 5
- Growth 3 of 5
- Profitability 2 of 5
- Financial health 0 of 5
- Dividend 3 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
Buy
Price target (mean) 22.64 +10.8% upside
Now 20.44
- Target (low)
- 19.00
- Target (mean)
- 22.64
- Target (high)
- 25.00
Ratings (0m) 16 6 buy · 10 hold · 0 sell
- Strong buy1
- Buy5
- Hold10
- Sell0
- Strong sell0
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate 0.14.
Financials — quick view
SBRA Revenue — quarterly 249.56M
SBRA Net income — quarterly 28.61M
SBRA EPS — quarterly 0.11
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | 0.1586 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | 0.1637 | 0.11 | -0.05 | -32.80% |
| Aug 3, 2026 | Jun 30, 2026 | 0.1711 | -0.10 | -0.27 | -158.45% |
| Apr 29, 2026 | Mar 31, 2026 | 0.1667 | 0.16 | -0.01 | -4.02% |
| Feb 12, 2026 | Dec 31, 2025 | 0.17 | 0.11 | -0.06 | -35.29% |
| Nov 5, 2025 | Sep 30, 2025 | 0.1834 | 0.094 | -0.09 | -48.75% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2026 | UBS | main | Neutral | Neutral |
| Oct 19, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 13, 2026 | UBS | main | Neutral | Neutral |
| Oct 13, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Baird | main | Neutral | Neutral |
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Country
- United States
- Website
- sabrahealth.com
News
The Roth IRA Mistake That Turns a 61-Year-Old’s $7,425 a Month in Tax-Free Dividends Into a Tax Bill 
UBS Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $22 
Sabra Health Care REIT Is A Buy After Q3 Shows More Portfolio Expansion 
Doctors' Offices, Labs and Nursing Homes Pay Rent to These 3 REITs, and $150,000 Yields $8,510 a Year 
5 Dividend Stocks With Ex-Dividend Deadlines This Week. The First Is Today 
Sabra Health Care REIT Q3 2026 Earnings Call Transcript 
Sabra Health Care REIT Raises FY2026 FFO Guidance from $1.53-$1.55 to $1.54-$1.55 vs $1.55 Est 
Sabra Health Care REIT Q3 FFO $0.39, Inline, Sales $249.565M Beat $232.392M Estimate 
Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21 
UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20
Your note
Sign in to keep a note on SBRA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Aug 30, 2026 | 159,033 |
| COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award(Grant) | Aug 30, 2026 | 470,870 |
| CUSACK CATHERINE | Director | Stock Award(Grant) | Aug 30, 2026 | 82,847 |
| FLORES JESSICA | Officer | Stock Award(Grant) | Aug 30, 2026 | 72,476 |
| FOSTER MICHAEL JEFFREY | Director | Sale | Nov 10, 2026 | 115,246 |
| KATZMANN LYNNE S. | Director | Stock Award(Grant) | Aug 30, 2026 | 86,912 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.89% | 41,614,351 | 850.60M | Jun 29, 2026 |
| Principal Financial Group, Inc. | 9.10% | 23,836,388 | 487.22M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 8.91% | 23,352,373 | 477.32M | Jun 29, 2026 |
| State Street Corporation | 4.81% | 12,605,529 | 257.66M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.33% | 11,349,125 | 231.98M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.95% | 7,731,739 | 158.04M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund | 3.66% | 9,591,242 | 196.04M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.47% | 9,099,666 | 186.00M | Sep 29, 2026 |
| Principal Funds, Inc-Real Estate Securities Fund | 3.16% | 8,264,998 | 168.94M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.05% | 8,001,962 | 163.56M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.54% | 6,655,161 | 136.03M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.21% | 5,786,194 | 118.27M | Jun 29, 2026 |